Compare TMDX & ARCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TMDX | ARCB |
|---|---|---|
| Founded | 1998 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Trucking Freight/Courier Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.7B |
| IPO Year | 2019 | 1994 |
| Metric | TMDX | ARCB |
|---|---|---|
| Price | $78.56 | $142.96 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 12 |
| Target Price | ★ $148.22 | $122.75 |
| AVG Volume (30 Days) | ★ 1.1M | 382.3K |
| Earning Date | 05-05-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 0.38% |
| EPS Growth | ★ 382.18 | N/A |
| EPS | ★ 0.20 | N/A |
| Revenue | $605,494,000.00 | ★ $1,657,864,000.00 |
| Revenue This Year | $24.25 | $7.00 |
| Revenue Next Year | $18.75 | $5.80 |
| P/E Ratio | $394.55 | ★ N/A |
| Revenue Growth | ★ 37.13 | 12.56 |
| 52 Week Low | $60.11 | $59.43 |
| 52 Week High | $156.00 | $176.69 |
| Indicator | TMDX | ARCB |
|---|---|---|
| Relative Strength Index (RSI) | 56.11 | 49.64 |
| Support Level | $64.90 | $112.62 |
| Resistance Level | $120.60 | N/A |
| Average True Range (ATR) | 4.22 | 8.06 |
| MACD | 1.88 | -1.80 |
| Stochastic Oscillator | 87.80 | 24.73 |
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
ArcBest Corp is an integrated logistics company that leverages technology and a full suite of shipping and logistics solutions to meet customers' supply chain needs. The company has two reportable operating segments: Asset-Based, which generates maximum revenue, and Asset-Light. The Asset-Based segment's operations include national, inter-regional, and regional transportation of general commodities through standard, expedited, and guaranteed less-than-truckload services. The Asset-Light segment represents the company's offerings in ground expedite, intermodal, household goods moving, managed transportation, warehousing and distribution, and international freight transportation for air, ocean, and ground.